Literature DB >> 11180061

Metabolic engineering of the nonmevalonate isopentenyl diphosphate synthesis pathway in Escherichia coli enhances lycopene production.

S W Kim1, J D Keasling.   

Abstract

Isopentenyl diphosphate (IPP) is the common, five-carbon building block in the biosynthesis of all carotenoids. IPP in Escherichia coli is synthesized through the nonmevalonate pathway, which has not been completely elucidated. The first reaction of IPP biosynthesis in E. coli is the formation of 1-deoxy-D-xylulose-5-phosphate (DXP), catalyzed by DXP synthase and encoded by dxs. The second reaction in the pathway is the reduction of DXP to 2-C-methyl-D-erythritol-4-phos- phate, catalyzed by DXP reductoisomerase and encoded by dxr. To determine if one or more of the reactions in the nonmevalonate pathway controlled flux to IPP, dxs and dxr were placed on several expression vectors under the control of three different promoters and transformed into three E. coli strains (DH5alpha, XL1-Blue, and JM101) that had been engineered to produce lycopene. Lycopene production was improved significantly in strains transformed with the dxs expression vectors. When the dxs gene was expressed from the arabinose-inducible araBAD promoter (P(BAD)) on a medium-copy plasmid, lycopene production was twofold higher than when dxs was expressed from the IPTG-inducible trc and lac promoters (P(trc) and P(lac), respectively) on medium-copy and high-copy plasmids. Given the low final densities of cells expressing dxs from IPTG-inducible promoters, the low lycopene production was probably due to the metabolic burden of plasmid maintenance and an excessive drain of central metabolic intermediates. At arabinose concentrations between 0 and 1.33 mM, cells expressing both dxs and dxr from P(BAD) on a medium-copy plasmid produced 1.4-2.0 times more lycopene than cells expressing dxs only. However, at higher arabinose concentrations lycopene production in cells expressing both dxs and dxr was lower than in cells expressing dxs only. A comparison of the three E. coli strains transformed with the arabinose-inducible dxs on a medium-copy plasmid revealed that lycopene production was highest in XL1-Blue. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180061     DOI: 10.1002/1097-0290(20000220)72:4<408::aid-bit1003>3.0.co;2-h

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  76 in total

Review 1.  Succinate production in Escherichia coli.

Authors:  Chandresh Thakker; Irene Martínez; Ka-Yiu San; George N Bennett
Journal:  Biotechnol J       Date:  2011-09-20       Impact factor: 4.677

2.  In silico identification of gene amplification targets for improvement of lycopene production.

Authors:  Hyung Seok Choi; Sang Yup Lee; Tae Yong Kim; Han Min Woo
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

3.  Engineering triterpene metabolism in tobacco.

Authors:  Shuiqin Wu; Zuodong Jiang; Chase Kempinski; S Eric Nybo; Satrio Husodo; Robert Williams; Joe Chappell
Journal:  Planta       Date:  2012-06-24       Impact factor: 4.116

4.  The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by Dxs.

Authors:  Amanda C Brown; Matthias Eberl; Dean C Crick; Hassan Jomaa; Tanya Parish
Journal:  J Bacteriol       Date:  2010-02-19       Impact factor: 3.490

5.  Tuning genetic control through promoter engineering.

Authors:  Hal Alper; Curt Fischer; Elke Nevoigt; Gregory Stephanopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-25       Impact factor: 11.205

6.  Establishing synthesis pathway-host compatibility via enzyme solubility.

Authors:  Sara A Amin; Venkatesh Endalur Gopinarayanan; Nikhil U Nair; Soha Hassoun
Journal:  Biotechnol Bioeng       Date:  2019-03-29       Impact factor: 4.530

7.  Laboratory-scale production of 13C-labeled lycopene and phytoene by bioengineered Escherichia coli.

Authors:  Chi-Hua Lu; Jin-Ho Choi; Nancy Engelmann Moran; Yong-Su Jin; John W Erdman
Journal:  J Agric Food Chem       Date:  2011-09-02       Impact factor: 5.279

8.  Type 2 IDI performs better than type 1 for improving lycopene production in metabolically engineered E. coli strains.

Authors:  Sara Abolhassani Rad; Hossein Shahbani Zahiri; Kambiz Akbari Noghabi; Sarah Rajaei; Reza Heidari; Leila Mojallali
Journal:  World J Microbiol Biotechnol       Date:  2011-06-28       Impact factor: 3.312

9.  Construction of an alternative glycerol-utilization pathway for improved β-carotene production in Escherichia coli.

Authors:  Jin-Ying Guo; Kun-Le Hu; Chang-Hao Bi; Qing-Yan Li; Xue-Li Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-05-11       Impact factor: 3.346

Review 10.  Synthetic biology: tools to design, build, and optimize cellular processes.

Authors:  Eric Young; Hal Alper
Journal:  J Biomed Biotechnol       Date:  2010-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.